Evidence map›Paper›PMID 32099069›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Loss of TNR causes a nonprogressive neurodevelopmental disorder with spasticity and transient opisthotonus.

Matias Wagner, Jonathan Lévy, Sabine Jung-Klawitter, Somayeh Bakhtiari, Fabiola Monteiro, Reza Maroofian, Tatjana Bierhals, Maja Hempel, Monique Elmaleh-Bergès, Joao P Kitajima and 22 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Canine paroxysmal dyskinesia-a review.Frontiers in veterinary science · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 17 institutions in 10 countries.

Matias Wagner *Institute of Human Genetics, Faculty of Medicine, Technical University München, Munich, Germany. matias.wagner@mri.tum.de.ORCID http://orcid.org/0000-0002-4454-8823
Jonathan Lévy *Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.
Sabine Jung-Klawitter *Division of Neuropediatrics and Metabolic Medicine, University Children's Hospital, Heidelberg, Germany.
Somayeh BakhtiariBarrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA.
Fabiola MonteiroMendelics Genomic Analysis, São Paulo, São Paulo, Brazil.
Reza MaroofianDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, UK.
Tatjana BierhalsInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Maja HempelInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Monique Elmaleh-BergèsDepartment of Pediatric Radiology, Robert Debré Hospital, AP-HP, Paris, France.
Joao P KitajimaMendelics Genomic Analysis, São Paulo, São Paulo, Brazil.
Chong A KimGenetic Unit, Instituto da Criança-HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Julia G SalomaoGenetic Unit, Instituto da Criança-HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
David J AmorMurdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Melbourne, VIC, Australia.
Monica S CooperMurdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Melbourne, VIC, Australia.
Laurence PerrinGenetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.
Eva PipirasDepartment of Cytogenetics, Jean-Verdier Hospital, Paris 13 University, Embryology and Histology, AP-HP, Bondy, France.
Axel NeuDepartment of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mohammad DoostiDepartment of Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran.
Ehsan G KarimianiGenetics Research Centre, Molecular and Clinical Sciences Institute, St. George's, University, London, UK.
Mehran B ToosiDepartment of Pediatric Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Henry HouldenDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, UK.
Sheng Chih JinLaboratory of Human Genetics and Genomics, The Rockefeller University, New York, NY, USA.
Yue C SiGeneDx, Gaithersburg, MD, USA.
Lance H RodanDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
Hanka VenselaarCentre for Molecular and Biomolecular Informatics, Radboud University Medical Centre, Nijmegen, The Netherlands.
Michael C KruerBarrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA.
Fernando KokMendelics Genomic Analysis, São Paulo, São Paulo, Brazil.
Georg F HoffmannDivision of Neuropediatrics and Metabolic Medicine, University Children's Hospital, Heidelberg, Germany.
Tim M StromInstitute of Human Genetics, Faculty of Medicine, Technical University München, Munich, Germany.
Saskia B WortmannInstitute of Human Genetics, Faculty of Medicine, Technical University München, Munich, Germany.
Anne-Claude Tabet *Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.
Thomas Opladen *Division of Neuropediatrics and Metabolic Medicine, University Children's Hospital, Heidelberg, Germany. Thomas.Opladen@med.uni-heidelberg.de.
Assistance Publique – Hôpitaux de Paris · FRHeidelberg University · DEMendelics · BRUniversität Hamburg · DEBarrow Neurological Institute · USNational Hospital for Neurology and Neurosurgery · GBRoyal Children's Hospital · AUUniversidade de São Paulo · BRBoston Children's Hospital · USHelmholtz Zentrum München · DEInstitut Pasteur · FRMashhad University of Medical Sciences · IRParacelsus Medical University · ATRadboud University Nijmegen · NLRockefeller University · USSt George's, University of London · GBUniversité Sorbonne Paris Nord · FR

Funding

Genomic Insights into the Neurobiology of Cerebral PalsyR01NS106298 · NINDS · UNIVERSITY OF ARIZONA · PI KRUER, MICHAEL C · 2019 to 2023
$3.7M
Integrative Genomic Analysis of Congenital Heart DiseaseK99HL143036 · NHLBI · ROCKEFELLER UNIVERSITY · PI JIN, SHENG CHIH · 2019 to 2019
$178k
Medical Research Council G0802760Medical Research Council G1001253Medical Research Council G108/638Medical Research Council MR/S01165X/1NHLBI NIH HHS K99 HL143036The Dunhill Medical Trust R605/0717
6 · The paper itself

Abstract

purposeTNR, encoding Tenascin-R, is an extracellular matrix glycoprotein involved in neurite outgrowth and neural cell adhesion, proliferation and migration, axonal guidance, myelination, and synaptic plasticity. Tenascin-R is exclusively expressed in the central nervous system with highest expression after birth. The protein is crucial in the formation of perineuronal nets that ensheath interneurons. However, the role of Tenascin-R in human pathology is largely unknown. We aimed to establish TNR as a human disease gene and unravel the associated clinical spectrum.

methodsExome sequencing and an online matchmaking tool were used to identify patients with biallelic variants in TNR.

resultsWe identified 13 individuals from 8 unrelated families with biallelic variants in TNR sharing a phenotype consisting of spastic para- or tetraparesis, axial muscular hypotonia, developmental delay, and transient opisthotonus. Four homozygous loss-of-function and four different missense variants were identified.

conclusionWe establish TNR as a disease gene for an autosomal recessive nonprogressive neurodevelopmental disorder with spasticity and transient opisthotonus and highlight the role of central nervous system extracellular matrix proteins in the pathogenicity of spastic disorders.

Indexed as

Muscle SpasticityNeurodevelopmental DisordersCentral Nervous SystemExtracellular MatrixHomozygoteHumanscerebral palsydevelopmental disorderexome sequencingspastic tetraparesisTNR

Identifiers

PMID32099069
OpenAlexW3007545458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.